Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Giulio Perugi, Alessandro Pallucchini, Salvatore Rizzato, Pietro De Rossi, Gabriele Sani, Angelo GI Maremmani, Vito Pinzone & Icro Maremmani. (2019) Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD). Expert Opinion on Pharmacotherapy 20:3, pages 343-355.
Read now
Read now
Articles from other publishers (14)
Olivia L. Ramey, Andrea E. Bonny, Armando Silva Almodóvar & Milap C. Nahata. (2022) Gaps in Evidence-based Treatment of Concurrent Attention Deficit Hyperactivity Disorder and Opioid Use Disorder: A Scoping Review. Annals of Pharmacotherapy 57:8, pages 978-990.
Crossref
Crossref
Jacqueline A Erler, Carl Hart & Christopher Medina-Kirchner. (2023) Inappropriate Conclusions Regarding Neurotoxicity in Methadone and Methamphetamine Users. Addiction and Health 15:3, pages 228-229.
Crossref
Crossref
Jørn Henrik Vold, Anne Halmøy, Fatemeh Chalabianloo, Marianne Cook Pierron, Else-Marie Løberg, Kjell Arne Johansson & Lars Thore Fadnes. (2023) Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study. BMC Psychiatry 23:1.
Crossref
Crossref
Margherita Barbuti, Marco Maiello, Vincenza Spera, Alessandro Pallucchini, Giulio E. Brancati, Angelo G. I. Maremmani, Giulio Perugi & Icro Maremmani. (2023) Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician. Journal of Clinical Medicine 12:9, pages 3096.
Crossref
Crossref
Carrie M. Mintz, Kevin Y. Xu, Ned J. Presnall, Sarah M. Hartz, Frances R. Levin, Jeffrey F. Scherrer, Laura J. Bierut & Richard A. Grucza. (2022) Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder. JAMA Network Open 5:5, pages e2211634.
Crossref
Crossref
Icro Maremmani, Vincenza Spera, Marco Maiello, Angelo G. I. Maremmani & Giulio Perugi. 2022. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder
179
198
.
Anja Plemenitaš Ilješ. 2021. ADHD - From Etiology to Comorbidity. ADHD - From Etiology to Comorbidity.
Sunsha Chamakalayil, Johannes Strasser, Marc Vogel, Serge Brand, Marc Walter & Kenneth M. Dürsteler. (2021) Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice. Frontiers in Psychiatry 11.
Crossref
Crossref
Jørn Henrik Vold, Christer Aas, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Anne Halmøy, Kjell Arne Johansson & Lars Thore Fadnes. (2020) Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017. BMC Psychiatry 20:1.
Crossref
Crossref
Robert Feder. (2020) Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice. The American Journal on Addictions 29:6, pages 508-514.
Crossref
Crossref
Jørn Henrik Vold, Christer Aas, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Johan Reutfors, Anne Halmøy, Kjell Arne Johansson & Lars Thore Fadnes. (2020) Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017. BMJ Open 10:8, pages e036860.
Crossref
Crossref
Yu-Jung Jenny Wei, Yanmin Zhu, Wei Liu, Regina Bussing & Almut G. Winterstein. (2018) Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder. JAMA Network Open 1:4, pages e181152.
Crossref
Crossref
Vanessa Pauly, Elisabeth Frauger, Magalie Lepelley, Michel Mallaret, Quentin Boucherie & Joëlle Micallef. (2018) Patterns and profiles of methylphenidate use both in children and adults. British Journal of Clinical Pharmacology 84:6, pages 1215-1227.
Crossref
Crossref
Kristine Fiksdal Abel, Edle Ravndal, Thomas Clausen & Jørgen G. Bramness. (2017) Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment. European Addiction Research 23:6, pages 298-305.
Crossref
Crossref